| Log in

New PE-backed diagnostics firms hurting growth, says Thyrocare founder

10 October, 2017

Diagnostics chain Thyrocare Technologies Ltd, which was listed on the stock exchanges last year, is seeing disruption from new-age private equity-backed diagnostics firms. Thyrocare founder and CEO A Velumani told VCCTV that the company is growing at a slower pace than its potential because of new labs that are funded by investors. He says the new labs are burning money as they are driven more by volumes than profit. Velumani also talks about the recent exit by multi-stage investment firm Norwest Venture Partners and expansion plans. For more, watch the video.

Like this video? Sign up for our daily newsletter to get our top reports & videos.


Leave Your Comment
Thyrocare to launch B2C venture Lab Nation, scouting for strategic investors

Thyrocare to launch B2C venture Lab Nation, scouting for strategic investors

Jasleen Kaur Batra 4 years ago
Thyrocare Technologies Ltd, India’s largest thyroid testing company, is...
How Thyrocare plans to expand after blockbuster IPO

How Thyrocare plans to expand after blockbuster IPO

Joseph Rai 2 years ago
Diagnostics chain Thyrocare Technologies Ltd, which made a spectacular stock...
Nueclear Healthcare raises $4M from Norwest Venture Partners

Nueclear Healthcare raises $4M from Norwest Venture Partners

Bhawna Gupta 5 years ago
Nueclear Healthcare Ltd, the low-cost cancer diagnosis services business of the...
No Comments

New PE-backed diagnostics firms hurting growth, says Thyrocare founder

Powered by WordPress.com VIP